0.4356

0.14% 0.0006

Moolec Science Sa (MLEC)

Overview News Price History Discussions Forecast

Moolec Science Sa stock is traded at $0.4356, with a volume of 19,960. It is up +0.14% in the last 24 hours and down -27.40% over the past month. Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Previous Close:

$0.435

Open:

$0.4441

24h Volume:

19,960

Relative Volume:

0.13

Market Cap:

$4.74M

Revenue:

$5.63M

Net Income/Loss:

$-7.31M

P/E Ratio:

-2.178

EPS:

-0.2

Net Cash Flow:

$-9.49M

1W Performance:

-6.78%

1M Performance:

-27.40%

6M Performance:

-93.71%

1Y Performance:

-94.81%

1-Day Range:

$0.42

$0.4499

1-Week Range:

$0.41

$0.4797

52-Week Range:

$0.3916

$10.47

Moolec Science Sa Stock (MLEC) Company Profile

Name

Moolec Science Sa

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-12-11

Latest SEC Filings

MLEC's Discussions on Twitter

Compare MLEC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MLEC Moolec Science Sa	0.4356	4.74M	5.63M	-7.31M	-9.49M	-0.20
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Moolec Science Sa Stock (MLEC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-27-23	Initiated	ROTH MKM	Buy

Moolec Science Sa Stock (MLEC) Latest News

Dec 12, 2025

Moolec Science adjourns shareholder meeting due to lack of quorum - Investing.com

Dec 12, 2025

Moolec Science Adjourns Shareholder Meeting to December 16, 2025 - TipRanks

Dec 12, 2025

Moolec receives Nasdaq non-compliance letter - MSN

Dec 12, 2025

What drives Moolec Science SA stock priceLow Beta Stocks & Free Stay Ahead With Picks - earlytimes.in

Dec 12, 2025

Dec 11, 2025

Moolec Science completes first large-scale safflower campaign - Investing.com

Dec 11, 2025

Moolec Science completes first large-scale safflower campaign By Investing.com - Investing.com South Africa

Dec 11, 2025

Moolec Science Scales GLASO U.S. Platform With Record 2025 Campaign and Expansion Into Nutrition & Supplements Market - ACCESS Newswire

Dec 11, 2025

How Moolec Science SA stock performs in rate cut cyclesWeekly Profit Analysis & Verified Stock Trade Ideas - moha.gov.vn

Dec 11, 2025

Dec 05, 2025

Moolec Science (NASDAQ:MLEC) Stock Price Up 9.3% – What’s Next? - Defense World

Dec 05, 2025

Dec 04, 2025

How Moolec Science SA stock benefits from global expansion2025 Technical Overview & Community Consensus Picks - Newser

Dec 04, 2025

Will Moolec Science SA stock gain from government policies2025 Growth vs Value & Smart Allocation Stock Reports - Newser

Dec 04, 2025

Dec 03, 2025

Moolec Science (MLEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 01, 2025